Eli Lilly and Company

Other

Anne Louise Tebbe

Michael Robert Wiley

Gerald Floyd Smith

John Joseph Masters

David Kent Herron

Ying Kwong Yee

David Mendel

Jason Scott Sawyer

Douglas Wade Beight

Steven E Hall

James Howard Wikel

Robert T Shuman

Valentine Joseph Klimkowski

Jennifer Marie Tinsley

Trelia Joyce Craft

Leonard Crayton Weir

Jeffry Bernard Franciskovich

Guy Milot

Theodore Goodson, Jr

Jeffrey Alan Kyle

Sajan Joseph

Marta Maria Pi&ntilde;eiro-N&uacute;&ntilde;ez

Carl Penman Denny

Angela Lynn Marquart

Marta Maria Pi&ntilde;eiro-Nu&ntilde;ez

Theodore Goodson, Junior

Leander Merritt

Andrew Michael Ratz

Marta Maria Pineiro-Nunez

Philip Parker Waid

Salvatore Donato Lepore

Jeffrey Bernard Franciskovich

Ankush Baburao Argade

Marta Maria Pinelro-Núnez

Guy Milet

Theodore Goodson Jr

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. An example of a compound of formula (I) is (a). 

Aromatic ether derivatives useful as thrombin inhibitors

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor. 

Substituted heterocyclic carboxamides with antithrombotic activity

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Aromatic amides

Antithrombotic amides

This application relates to heteroaromatic amides (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Heteroroaromatic amides as inhibitor of factor Xa

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Antithrombotic agents

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermidates thereof.

Growing community of inventors

Hamburg, Germany

Anne Louise Tebbe